rdf:type |
|
lifeskim:mentions |
umls-concept:C0014518,
umls-concept:C0014742,
umls-concept:C0017262,
umls-concept:C0038325,
umls-concept:C0086860,
umls-concept:C0123759,
umls-concept:C0185117,
umls-concept:C0205250,
umls-concept:C0229671,
umls-concept:C0253023,
umls-concept:C0282554,
umls-concept:C0337810,
umls-concept:C0441889,
umls-concept:C1257890,
umls-concept:C1332680,
umls-concept:C1423842,
umls-concept:C1609432,
umls-concept:C1749467,
umls-concept:C2603343,
umls-concept:C2911684
|
pubmed:issue |
4
|
pubmed:dateCreated |
2007-4-26
|
pubmed:abstractText |
No data exist as to Th2 chemokines in erythema multiforme (EM) and Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/CCL17 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/CCL22 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL17,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL22,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokine CCL5,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokines,
http://linkedlifedata.com/resource/pubmed/chemical/Chemokines, CC,
http://linkedlifedata.com/resource/pubmed/chemical/Fas Ligand Protein,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-12
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1421-9832
|
pubmed:author |
pubmed-author:AntigaEmilianoE,
pubmed-author:BernengoMaria GraziaMG,
pubmed-author:CaproniMarziaM,
pubmed-author:De SimoneClaraC,
pubmed-author:Del BiancoElenaE,
pubmed-author:FabbriPaoloP,
pubmed-author:FrezzoliniAlessandraA,
pubmed-author:Italian Group of Immunopathology,
pubmed-author:MarzanoAngeloA,
pubmed-author:Osella-AbateSimonaS,
pubmed-author:ParodiAuroraA,
pubmed-author:QuaglinoPietroP,
pubmed-author:SavoiaPaolaP,
pubmed-author:SchenaDonatellaD,
pubmed-author:VolpiWalterW
|
pubmed:copyrightInfo |
2007 S. Karger AG, Basel
|
pubmed:issnType |
Electronic
|
pubmed:volume |
214
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
296-304
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17460400-Adolescent,
pubmed-meshheading:17460400-Adult,
pubmed-meshheading:17460400-Aged,
pubmed-meshheading:17460400-Aged, 80 and over,
pubmed-meshheading:17460400-Chemokine CCL17,
pubmed-meshheading:17460400-Chemokine CCL22,
pubmed-meshheading:17460400-Chemokine CCL5,
pubmed-meshheading:17460400-Chemokines,
pubmed-meshheading:17460400-Chemokines, CC,
pubmed-meshheading:17460400-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:17460400-Epidermal Necrolysis, Toxic,
pubmed-meshheading:17460400-Erythema Multiforme,
pubmed-meshheading:17460400-Fas Ligand Protein,
pubmed-meshheading:17460400-Female,
pubmed-meshheading:17460400-Humans,
pubmed-meshheading:17460400-Interleukin-12,
pubmed-meshheading:17460400-Male,
pubmed-meshheading:17460400-Middle Aged,
pubmed-meshheading:17460400-Prospective Studies,
pubmed-meshheading:17460400-Stevens-Johnson Syndrome,
pubmed-meshheading:17460400-Th1 Cells,
pubmed-meshheading:17460400-Th2 Cells
|
pubmed:year |
2007
|
pubmed:articleTitle |
Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
|
pubmed:affiliation |
Department of Biomedical Sciences and Human Oncology, Section of Dermatology, 1st Dermatologic Clinic, University of Turin, Turin, Italy. pietro.quaglino@unito.it
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|